i2.JP (Innovation Infusion Japan)i2.JP (Innovation Infusion Japan)

Healthcare Innovation
Engine to Realize
"patient centricity"

Our mission

The era when the word "new normal" is swirling around
Things keep changing
― External environment, technology evolution, mixed culture and values
Things that will not change
― Patients fighting against diseases,
healthcare professionals working hard day-to-day,
we, people who have the passion and power to contribute

i2.JP is an open innovation initiative to connect healthcare professionals,
local governments, academia and private companies,
designed to jointly work out collective and practical optimal answers toward the solution of issues in the healthcare field.

4 challenges i2.JP will tackle

  • 1

    Realize "patient centricity"

  • 2

    Deliver added value solution to healthcare professionals

  • 3

    Discover and develop new technologies contributing to patients and healthcare professionals

  • 4

    Optimize healthcare systems

Initiatives i2.JP is eager to promote together with "partners"

Realize "patient centricity", deliver added value solution to healthcare professionals, discover and develop new technologies, optimize healthcare systems - all of these are challenges difficult to deliver by a single group or a single individual.

i2.JP will create opportunities of collaboration with start-ups, healthcare professionals, and partners from the private sector, government and academia.

Toward the solution of specific healthcare issues, i2.JP will jointly promote "Think big (comprehension and verbalization of the big picture), start small (understanding and identification of pain points, development of MVP, promotion of PoC), learn and scale fast (learnings from mistakes, market-in and expansion strategy)."

Start-up/Healthcare professionals/Government, private sector, academia

Areas i2.JP to focus on: "4D+E"

i2.JP creates synergies between
"4D (Diagnosis, Device, Digital, Drug) + E (Experience design)"
for building future healthcare

  • 1

    Diagnosis

  • 2

    Device

  • 3

    Digital

  • 4

    Drug

  • 4

    Experience Design

i2.JP will focus on 4D, namely, Diagnosis, Device, Digital and Drug, as its technology fields and create solutions and services for patients and healthcare professionals.
In addition, we will focus on experience design to understand and recognize pain points and unmet needs of patients and healthcare professionals, from a market-in viewpoint.
We will deliver solutions and services which correspoding to patients and healthcare professionals with the shortest distance.

Global collaboration leveraging i2.JP

i2.JP is a member of 10+ AstraZeneca Healthcare Innovation Hubs across the world.

These hubs promote open innovation in their local markets and build up networks.

Sweden's BioventureHub and China's I-Campus have incubation facilities pushing forward start-up support jointly with their partners from government, the private sector and academia.

Israel's BeyondBio has formed strategic partnership with local medical institutions, providing an environment for start-ups to validate MVPs.

AstraZeneca has accelerated opening of hubs both in the established markets and emerging markets in recent years, developing a global network.

i2.JP will support both Japanese start-ups going international and overseas start-ups coming into Japan by leveraging collaborations with the network.

AstraZeneca Healthcare Innovation HubsAstraZeneca Healthcare Innovation Hubs
HTML HTML HTML HTML HTML HTML

i2.JP is looking for partners to engage in healthcare innovation together

To innovators in start-ups, healthcare facilities, local governments, academia and private companies

i2.JP is always welcoming members who want to jointly engage in solving healthcare issues and creating healthcare innovation! For inquiries about our ongoing initiatives and potential collaboration with us, please feel free to contact us.

Partners

  • AstraZenecaAstraZeneca
  • I&H Co.,Ltd.
  • I'm beside youI'm beside you
  • anamne Inc.
  • Eli Lilly Japan K.K.
  • Integrity Healthcare Co., Ltd.
  • welbywelby
  • ExaWizardsExaWizardsExaWizards
  • LPIXELLPIXELLPIXEL
  • Oishi Kenko Inc.
  • OSAKA INNOVATION HUBOSAKA INNOVATION HUBOSAKA INNOVATION HUB
  • omronomron
  • Kyo Diagnostics Co., Ltd.
  • x Bridge-Tokyo
  • Cambridge Consultants LtdCambridge Consultants LtdCambridge Consultants Ltd
  • CO-DEJIMA
  • KONICA MINOLTA, INC.
  • KOBATA
  • COMMONEY Co., Ltd.
  • conversationHEALTHconversationHEALTHconversationHEALTH
  • C3 Kabushiki Kaisha
  • joconne
  • 3Rock KK.
  • zeniuszeniuszenius
  • genoplangenoplangenoplan
  • Sugi HoldingsSugi HoldingsSugi Holdings
  • Direct RF Co.,Ltd.
  • DATACKDATACKDATACK
  • TECHBLITZTECHBLITZTECHBLITZ
  • Deloitte Tohmatsu Consulting LLC
  • tenup, Inc
  • TOKYO INNOVATION ECOSYSTEMSTOKYO INNOVATION ECOSYSTEMSTOKYO INNOVATION ECOSYSTEMS
  • TYRETINGTYRETING
  • Bisu, Inc.Bisu, Inc.Bisu, Inc.
  • NORDIC INNOVATION HOUSE, TokyoNORDIC INNOVATION HOUSE, TokyoNORDIC INNOVATION HOUSE, Tokyo
  • Beyond Next VenturesBeyond Next VenturesBeyond Next Ventures
  • Plusman LLC
  • Flora MaternityFlora MaternityFlora Maternity
  • MICINMICIN
  • MILK Co., LtdMILK Co., LtdMILK Co., Ltd
  • MEPLA Japan Co., Ltd.MEPLA Japan Co., Ltd.MEPLA Japan Co., Ltd.
  • MediFrameMediFrameMediFrame
  • Ubie, Inc.Ubie, Inc.
  • Lab Tech
  • For inquiries

    Interested in joining us?

  • Please confirm the Privacy Policy
    before sending your inquiry

Thank you for your interest. We will get in touch soon.